Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients

This study has been completed.
Sponsor:
Collaborator:
University of Turin, Italy
Information provided by (Responsible Party):
Paolo Zola, Azienda Ospedaliera San Giovanni Battista
ClinicalTrials.gov Identifier:
NCT01523652
First received: July 5, 2011
Last updated: January 30, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2008
  Estimated Primary Completion Date: No date given
No publications provided by Azienda Ospedaliera San Giovanni Battista

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):